500
T. Miura et al.
PAPER
13C NMR (100 MHz, CDCl3): δ = 44.9, 112.6, 118.0, 124.1 (q,
MS (EI): m/z (%) = 276 (M+, 100.0), 248 (46.7), 233 (42.0), 191
(92.5).
HRMS (EI): m/z [M]+ calcd for C15H13FO4: 276.0798; found:
276.0796.
3
1JC,F = 262.2 Hz), 125.5 (q, JC,F = 3.8 Hz, 2 C), 129.3 (q,
2JC,F = 32.2 Hz), 129.9 (2 C), 137.9, 146.8, 152.2, 185.6.
MS (EI): m/z (%) = 254 (M+, 5.3), 95 (100.0).
HRMS (EI): m/z [M]+ calcd for C13H9F3O2: 254.0554; found:
254.0559.
Methyl 6-Ethyl-2-oxo-5-[4-(trifluoromethyl)phenyl]-2H-pyran-
3-carboxylate (8c)
Following the typical procedure for 8a using 7c (521 mg, 2.41
mmol) gave 8c as a pale yellow amorphous solid; yield: 513 mg
(65%, 2 steps).
IR (CHCl3): 1765, 1742, 1713, 1545 cm–1.
1-Phenyl-2-(2-thienyl)ethanone (15)
Following the typical procedure for 12 using thiophene-2-acetic
acid (14, 1.00 g, 7.03 mmol) gave 15 as a white amorphous solid;
yield: 1.00 g (70%).
1H NMR (400 MHz, CDCl3): δ = 1.28 (t, J = 7.6 Hz, 3 H), 2.60 (q,
J = 7.6 Hz, 2 H), 3.92 (s, 3 H), 7.41 (dd, J = 0.6, 8.7 Hz, 2 H), 7.73
(dd, J = 0.6, 8.7 Hz, 2 H), 8.20 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 11.9, 25.6, 52.8, 114.2, 116.6,
123.8 (q, 1JC,F = 270.5 Hz), 126.0 (q, 3JC,F = 4.0 Hz, 2 C), 129.3 (2
C), 130.7 (q, 2JC,F = 32.6 Hz), 138.4, 151.8, 157.6, 163.8, 170.2.
MS (EI): m/z (%) = 326 (M+, 100.0), 298 (63.3), 283 (49.6), 241
(61.8).
HRMS (EI): m/z [M]+ calcd for C16H13F3O4: 326.0766; found:
326.0769.
IR (CHCl3): 1686, 1599 cm–1.
1H NMR (400 MHz, CDCl3): δ = 4.490 (br s, 1 H), 4.493 (br s, 1 H),
6.93–6.95 (m, 1 H), 6.97 (dd, J = 3.2, 5.0 Hz, 1 H), 7.23 (dd, J = 1.6,
5.0 Hz, 1 H), 7.46–7.50 (m, 2 H), 7.58 (tt, J = 1.4, 7.6 Hz, 1 H),
8.01–8.04 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 39.4, 125.1, 126.8, 126.9, 128.6
(2 C), 128.7 (2 C), 133.4, 135.5, 136.1, 196.0.
MS (EI): m/z (%) = 202 (M+, 27.8), 105 (100.0), 97 (20.5), 77
(70.9).
HRMS (EI): m/z [M]+ calcd for C12H10O4S: 202.0452; found:
202.0449.
Methyl 6-Ethyl-5-(4-nitrophenyl)-2-oxo-2H-pyran-3-carboxyl-
ate (8d)
Following the typical procedure for 8a using 7d (1.02 g, 5.29 mmol)
gave 8d as yellowish prisms; yield: 1.06 g (66%, 2 steps); mp 132–
135 °C (n-hexane–EtOAc).
Methyl 6-Ethyl-2-oxo-5-phenyl-2H-pyran-3-carboxylate (8a);
Typical Procedure for 6-Substituted 3-(Alkoxycarbonyl)-5-
aryl-α-pyrones
To a stirred suspension of 1-phenylbutan-2-one (7a, 1.00 mL, 6.68
mmol) and 5 Å MS (508 mg) in DMSO (20 mL) was added NaH
(60% in oil, 294 mg, 7.35 mmol) in one portion at r.t. and the mix-
ture was stirred for 1 h. Dimethyl methoxymethylenemalonate (5,
1.40 g, 8.02 mmol) in DMSO (10 mL) was added at r.t. and the mix-
ture was stirred for 22 h. After acidification with aq 1 M HCl to pH
4 in an ice water bath, the mixture was filtered over Celite® pad and
the filtrate was extracted with Et2O (3 ×). The combined organic
layer was washed with H2O, dried (Na2SO4), filtered, and concen-
trated in vacuo to give the crude material as a yellow oil (2.27 g).
The crude material was dissolved in AcOH (40 mL) and the solution
was refluxed (oil bath temp: 135 °C). After 16 h, the mixture was
concentrated in vacuo to afford the crude product as an orange oil.
The crude product was purified by column chromatography (silica
gel, n-hexane–EtOAc, 3:1) to give 8a (1.38 g, 80%) as a pale yellow
oil.
IR (KBr): 1753, 1709, 1599, 1547, 1524 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.30 (t, J = 7.4 Hz, 3 H), 2.61 (q,
J = 7.4 Hz, 2 H), 3.92 (s, 3 H), 7.48 (dt, J = 2.2, 9.0 Hz, 2 H), 8.20
(s, 1 H), 8.33 (dt, J = 2.2, 9.0 Hz, 2 H).
13C NMR (100 MHz, CDCl3): δ = 11.9, 25.7, 52.8, 114.4, 115.9,
124.2 (2 C), 129.9 (2 C), 141.3, 147.7, 151.2, 157.2, 163.6, 170.4.
MS (EI): m/z (%) = 303 (M+, 100.0), 275 (84.0), 260 (39.7), 218
(62.4).
HRMS (EI): m/z [M]+ calcd for C15H13NO6: 303.0743; found:
303.0741.
Methyl 6-Ethyl-5-(4-methoxyphenyl)-2-oxo-2H-pyran-3-car-
boxylate (8e)
Following the typical procedure for 8a using 7e (1.03 g, 5.78 mmol)
gave 8e as a yellowish oil; yield: 1.21 g (73%, 2 steps).
IR (CHCl3): 1761, 1744, 1709, 1541 cm–1.
1H NMR (270 MHz, CDCl3): δ = 1.26 (t, J = 7.6 Hz, 3 H), 2.60 (q,
J = 7.6 Hz, 2 H), 3.91 (s, 3 H), 7.24–7.49 (m, 5 H), 8.23 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 11.9, 25.5, 52.6, 113.7, 117.9,
128.3, 128.8 (2 C), 129.0 (2 C), 134.7, 152.6, 158.0, 164.0, 169.9.
IR (CHCl3): 1759, 1740, 1709, 1611, 1541 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.25 (t, J = 7.6 Hz, 3 H), 2.60 (q,
J = 7.6 Hz, 2 H), 3.85 (s, 3 H), 3.90 (s, 3 H), 6.95–6.99 (m, 2 H),
7.16–7.20 (m, 2 H), 8.20 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 11.9, 25.5, 52.6, 55.3, 113.6,
114.3 (2 C), 117.5, 126.8, 130.0 (2 C), 152.9, 158.1, 159.6, 164.1,
169.7.
MS (EI): m/z (%) = 288 (M+, 85.5), 256 (35.5), 227 (100.0), 203
(57.1).
MS (EI): m/z (%) = 258 (M+, 100.0), 197 (79.4), 173 (90.2), 115
(52.3).
HRMS (EI): m/z [M]+ calcd for C15H14O4: 258.0892; found:
258.0901.
Methyl 6-Ethyl-5-(4-fluorophenyl)-2-oxo-2H-pyran-3-carbox-
ylate (8b)
Following the typical procedure for 8a using 7b (389 mg, 2.52
mmol) gave 8b as a yellowish oil; yield: 473 mg (68%, 2 steps).
HRMS (EI): m/z [M]+ calcd for C16H16O5: 288.0997; found:
288.0996.
Methyl 5-(Biphenyl-4-yl)-6-ethyl-2-oxo-2H-pyran-3-carboxyl-
ate (8f)
Following the typical procedure for 8a using 7f (1.09 g, 4.85 mmol)
gave 8f as a yellowish foam; yield: 920 mg (57%, 2 steps).
IR (CHCl3): 1763, 1742, 1711, 1541 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.26 (t, J = 7.6 Hz, 3 H), 2.56 (q,
J = 7.6 Hz, 2 H), 3.91 (s, 3 H), 7.12–7.18 (m, 2 H), 7.21–7.26 (m, 2
H), 8.18 (s, 1 H).
IR (CHCl3): 1761, 1740, 1709, 1541 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.29 (t, J = 7.6 Hz, 3 H), 2.66 (q,
J = 7.6 Hz, 2 H), 3.91 (s, 3 H), 7.32–7.50 (m, 5 H), 7.60–7.69 (m, 4
H), 8.27 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 11.9, 25.5, 52.7, 113.8, 116.1 (d,
3
2JC,F = 21.6 Hz, 2 C), 116.9, 130.6 (d, JC,F = 8.4 Hz, 2 C), 130.7,
152.4, 157.9, 162.6 (d, 1JC,F = 247.4 Hz), 164.0, 170.0.
Synthesis 2014, 46, 496–502
© Georg Thieme Verlag Stuttgart · New York